{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:45:53Z","timestamp":1784223953257,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Evidence shows that earlier access to Antiretroviral Therapy (ART) helps to increase the survival of children by delaying the progression to advanced stages of HIV-related diseases. However, the effect of testing and treatment strategies on mortality among children receiving ART has remained a limited study in Ethiopia. This study aimed to assess the incidence of mortality and its predictors among HIV-infected children receiving ART in Amhara Region Specialized Hospitals, after the test and treat strategy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A multicenter facility-based retrospective follow-up study was conducted on 475 HIV-infected children receiving ART at Amhara Region Comprehensive Specialized Hospitals from June 10, 2014, to February 28, 2022. A simple random sampling technique was used to select the study participants. Data were collected using national antiretroviral intake and follow-up forms via the KoBo Toolbox. Data analysis was done using STATA version 17. Descriptive analyses were summarized using the Kaplan-Meier curve, and a log-rank test was used to estimate and compare. Both bivariable and multivariable Weibull regression model were fitted to identify predictors of mortality. Finally, an adjusted hazard ratio with 95% CI was computed, and variables having a p-value\u2009&lt;\u20090.05 were considered as statistically significant predictors of mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among the 461 (97.1%) records included in the final analysis [42], 9.11% of the individuals died within the follow-up period. In this study, the overall mortality rate was found to be 2.53 per 100 child-year observations (95% Confidence Interval (CI): 1.87, 3.43). HIV-infected children presenting with opportunistic infections (OIs) other than tuberculosis infection (adjusted hazard ratio (AHR): 3.81, 95% CI: 1.66, 8.72), tuberculosis (AHR: 7.14, 95% CI: 2.86, 17.79), wasting (AHR: 2.83, 95% CI: 1.44, 5.56), and advanced disease staging (AHR: 4.02, 95% CI: 1.84, 8.78) were at higher risk of mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In this study, the mortality rate was high after the test-and-treat strategy. HIV-infected children presenting with OIs, advanced disease staging, and wasting were at higher risk of mortality. Therefore, to increase the survival rate for HIV-positive children, clinicians should place a strong emphasis on early screening, controlling OIs, and optimizing nutritional supplements.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13052-025-01872-5","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:47:12Z","timestamp":1741348032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Incidence of mortality and its predictors among HIV-infected children receiving antiretroviral therapy in Amhara region: a multicenter retrospective follow-up study"],"prefix":"10.1186","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-7794","authenticated-orcid":false,"given":"Gebrehiwot Berie","family":"Mekonnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sileshi","family":"Mulatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruck Tesfaye","family":"Legesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengistu Abebe","family":"Messelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikadie Dagnew","family":"Baye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birara Ayichew","family":"Tilaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengistu Melak","family":"Fekadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiruye Azene","family":"Demile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asnake Gashaw","family":"Belayneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sosina Tamre","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeshimebet Tamir","family":"Tsehay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousman","family":"Adal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betelhem Amha","family":"Haile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birhanu Mengist","family":"Munie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Tsedalu","family":"Amare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bekalu Mekonen","family":"Belay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubet Tazeb","family":"Wondie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"1","key":"1872_CR1","doi-asserted-by":"publisher","first-page":"S197","DOI":"10.1097\/QAD.0000000000002983","volume":"35","author":"K Heath","year":"2021","unstructured":"Heath K, Levi J, Hill A. The Joint United Nations Programme on HIV\/AIDS 95-95-95 targets: worldwide clinical and cost benefits of generic manufacture. AIDS. 2021;35(1):S197\u2013203.","journal-title":"AIDS"},{"issue":"1","key":"1872_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/GRF.0000000000000330","volume":"61","author":"HB Bernstein","year":"2018","unstructured":"Bernstein HB, Wegman AD. HIV infection: antepartum treatment and management. Clin Obstet Gynecol. 2018;61(1):122\u201336.","journal-title":"Clin Obstet Gynecol"},{"key":"1872_CR3","unstructured":"2023. WAd. FACT SHEET, global HIV statistics. UNAIDS 2023 epidemiological estimates. UNAIDS; 2023."},{"key":"1872_CR4","volume-title":"The global burden of Disease 2004 Update","author":"WH Organization","year":"2008","unstructured":"Organization WH. The global burden of Disease 2004 Update. Geneva, Switzerland:: World Health Organization; 2008."},{"key":"1872_CR5","unstructured":"EPHI H. Related estimates and projections for Ethiopia\u20132017. Ethiop Public Health Inst. 2017."},{"key":"1872_CR6","unstructured":"UNAIDS, Global AIDS. update Geneva Switzerland available from http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/global-AIDS-update-2016_en.pdf. access date. December 27,2016. 2016. p. p3."},{"issue":"4","key":"1872_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0b013e318207a55b","volume":"56","author":"P Lumbiganon","year":"2011","unstructured":"Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011;56(4):365\u201371.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"1872_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/INF.0000000000000454","volume":"33","author":"J Nugent","year":"2014","unstructured":"Nugent J, Edmonds A, Lusiama J, Thompson D, Behets F. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting. Pediatr Infect Dis J. 2014;33(11):1148\u201355.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1872_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12889-019-6444-7","volume":"19","author":"JN Mutanga","year":"2019","unstructured":"Mutanga JN, Mutembo S, Ezeamama AE, Song X, Fubisha RC, Mutesu-Kapembwa K, et al. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003\u20132015). BMC Public Health. 2019;19(1):115.","journal-title":"BMC Public Health"},{"issue":"1","key":"1872_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.medmal.2016.07.003","volume":"47","author":"AE Njom Nlend","year":"2017","unstructured":"Njom Nlend AE, Loussikila AB. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy. Med et maladies Infectieuses. 2017;47(1):32\u20137.","journal-title":"Med et maladies Infectieuses"},{"key":"1872_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2431-10-33","volume":"10","author":"DC Wamalwa","year":"2010","unstructured":"Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, Inwani I, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:33.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1872_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12887-022-03693-5","volume":"22","author":"GG Alemu","year":"2022","unstructured":"Alemu GG, Nigussie ZM, Amlak BT, Achamyeleh AA. Survival time and predictors of death among HIV infected under five children after initiation of anti -retroviral therapy in West Amhara Referral hospitals, Northwest Ethiopia. BMC Pediatr. 2022;22(1):670.","journal-title":"BMC Pediatr"},{"issue":"1","key":"1872_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13052-018-0472-2","volume":"44","author":"A Alebel","year":"2018","unstructured":"Alebel A, Wagnew F, Tesema C, Kibret GD, Petrucka P, Eshite S. Effects of undernutrition on survival of human immunodeficiency virus positive children on antiretroviral therapy. Ital J Pediatr. 2018;44(1):29.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"1872_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2431-12-161","volume":"12","author":"DN Koye","year":"2012","unstructured":"Koye DN, Ayele TA, Zeleke BM. Predictors of mortality among children on antiretroviral therapy at a referral hospital, Northwest Ethiopia: a retrospective follow up study. BMC Pediatr. 2012;12(1):161.","journal-title":"BMC Pediatr"},{"key":"1872_CR15","doi-asserted-by":"crossref","unstructured":"Gemechu J, Gebremichael B, Tesfaye T, Seyum A, Erkalo D. Predictors of mortality among TB-HIV co-infected children attending anti-retroviral therapy clinics of selected public hospitals in southern, Ethiopia: retrospective cohort study. 2022;80(1):11.","DOI":"10.1186\/s13690-021-00713-1"},{"issue":"6","key":"1872_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/09540121.2014.997180","volume":"27","author":"G Ebissa","year":"2015","unstructured":"Ebissa G, Deyessa N, Biadgilign S. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia. AIDS Care. 2015;27(6):723\u201330.","journal-title":"AIDS Care"},{"issue":"11","key":"1872_CR17","doi-asserted-by":"publisher","first-page":"e063879","DOI":"10.1136\/bmjopen-2022-063879","volume":"12","author":"CT Leshargie","year":"2022","unstructured":"Leshargie CT, Demant D, Burrowes S, Frawley J. Incidence and predictors of mortality among adolescents on antiretroviral therapy in Amhara Region, Ethiopia: a retrospective cohort analysis. BMJ open. 2022;12(11):e063879.","journal-title":"BMJ open"},{"key":"1872_CR18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/1471-2458-13-1047","volume":"13","author":"A Gebremedhin","year":"2013","unstructured":"Gebremedhin A, Gebremariam S, Haile F, Weldearegawi B, Decotelli C. Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle Hospital, Northern Ethiopia: a retrospective cohort study. BMC Public Health. 2013;13:1047.","journal-title":"BMC Public Health"},{"key":"1872_CR19","unstructured":"Adem AK, Alem D, Girmatsion F. Factors affecting survival of HIV positive children taking antiretroviral therapy at Adama Referral Hospital and Medical College. Ethiopia J AIDS Clin Res. 2014;5(3)."},{"key":"1872_CR20","doi-asserted-by":"crossref","unstructured":"Chekole B, Belachew A, Geddif A, Amsalu E, Tigabu A. Survival status and predictors of mortality among HIV-positive children initiated antiretroviral therapy in Bahir Dar town public health facilities Amhara region, Ethiopia, 2020. 2022;10:20503121211069477.","DOI":"10.1177\/20503121211069477"},{"key":"1872_CR21","doi-asserted-by":"crossref","unstructured":"Dawit Z, Abebe S, Dessu S. Incidence and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at public hospitals in Southern Ethiopia. 2021;16(6):e0253449.","DOI":"10.1371\/journal.pone.0253449"},{"key":"1872_CR22","doi-asserted-by":"publisher","first-page":"205031211983895","DOI":"10.1177\/2050312119838957","volume":"7","author":"G Arage","year":"2019","unstructured":"Arage G, Assefa M, Worku T, Semahegn A. Survival rate of HIV-infected children after initiation of the antiretroviral therapy and its predictors in Ethiopia: a facility-based retrospective cohort. SAGE open Med. 2019;7:2050312119838957.","journal-title":"SAGE open Med"},{"issue":"1","key":"1872_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09418-6","volume":"20","author":"A Alebel","year":"2020","unstructured":"Alebel A, Engeda EH, Kelkay MM, Petrucka P, Kibret GD, Wagnew F, et al. Mortality rate among HIV-positive children on ART in Northwest Ethiopia: a historical cohort study. BMC Public Health. 2020;20(1):1\u201311.","journal-title":"BMC Public Health"},{"issue":"1","key":"1872_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40545-022-00448-6","volume":"15","author":"Y Biyazin","year":"2022","unstructured":"Biyazin Y, Wondwossen K, Wubie AB, Getachew M, Gebremichael B. Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals. J Pharm Policy Pract. 2022;15(1):48.","journal-title":"J Pharm Policy Pract"},{"issue":"4","key":"1872_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5897\/JAHR2018.0459","volume":"10","author":"AA Asrat","year":"2018","unstructured":"Asrat AA, Yemane A. Survival time of human immunodeficiency virus (HIV) infected children under 15 years of age after initiation of antiretroviral therapy in the University of Gondar Comprehensive Specialized Hospital, Ethiopia. J AIDS HIV Res. 2018;10(4):49\u201355.","journal-title":"J AIDS HIV Res"},{"key":"1872_CR26","doi-asserted-by":"crossref","unstructured":"Sidamo N, Debere M, Enderis B, Abyu D. Incidence and predictors of mortality among children on anti-retroviral therapy in public health facilities of Arba Minch town, Gamo Gofa Zone, southern Ethiopia; retrospective cohort study. Clin Mother Child Health. 2017;14(3).","DOI":"10.4172\/2090-7214.1000267"},{"issue":"2","key":"1872_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/2325957413500852","volume":"14","author":"RS Mwiru","year":"2015","unstructured":"Mwiru RS, Spiegelman D, Duggan C, Seage GR III, Semu H, Chalamilla G, et al. Nutritional status and other baseline predictors of mortality among HIV-infected children initiating antiretroviral therapy in Tanzania. J Int Association Providers AIDS Care (JIAPAC). 2015;14(2):172\u20139.","journal-title":"J Int Association Providers AIDS Care (JIAPAC)"},{"key":"1872_CR28","first-page":"1","volume-title":"National guidlines for comprhensive HIV prevention,care and treatment in Ethiopia","author":"FMOH","year":"2014","unstructured":"FMOH. National guidlines for comprhensive HIV prevention,care and treatment in Ethiopia. Addis Ababa: FMOH; 2014. pp. 1\u2013165."},{"key":"1872_CR29","unstructured":"Orginization. WH. HIV. WHO; 2024."},{"key":"1872_CR30","first-page":"1","volume-title":"Care and Treatment Training for Healthcare Providers","author":"HIV National Comprehensive","year":"2021","unstructured":"FMOH, National Comprehensive HIV, Prevention. In: Health, Mo, editors. Care and Treatment Training for Healthcare Providers. Addis Ababa: Ethiopian Federal Ministry of Health Revised on August; 2021. pp. 1\u2013502."},{"issue":"10144","key":"1872_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(18)31070-5","volume":"392","author":"L-G Bekker","year":"2018","unstructured":"Bekker L-G, Alleyne G, Baral S, Cepeda J, Daskalakis D, Dowdy D, et al. Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society\u2014Lancet Commission. Lancet. 2018;392(10144):312\u201358.","journal-title":"Lancet"},{"key":"1872_CR32","unstructured":"Health. Mo. Health Sector Transformation Plan II(HSTP- II). Addis AbabaFebruary, 2021."},{"key":"1872_CR33","doi-asserted-by":"publisher","first-page":"205031212110694","DOI":"10.1177\/20503121211069477","volume":"10","author":"B Chekole","year":"2022","unstructured":"Chekole B, Belachew A, Geddif A, Amsalu E, Tigabu A. Survival status and predictors of mortality among HIV-positive children initiated antiretroviral therapy in Bahir Dar town public health facilities Amhara region, Ethiopia, 2020. SAGE Open Med. 2022;10:20503121211069477.","journal-title":"SAGE Open Med"},{"issue":"4","key":"1872_CR34","first-page":"235","volume":"25","author":"A Mulugeta","year":"2017","unstructured":"Mulugeta A, Assefa H, Tewelde T, Dube L. Determinants of survival among HIV positive children on antiretroviral therapy in public hospitals, Addis Ababa, Ethiopia. Qual Prim Care. 2017;25(4):235\u201341.","journal-title":"Qual Prim Care"},{"key":"1872_CR35","volume-title":"National guidlines for comprehensive HIV prevntion, care and treatment in Ethiopia. Prevention, screening, and management of common co infections","author":"Federal Minstry of Health","year":"2018","unstructured":"Federal Minstry of Health. National guidlines for comprehensive HIV prevntion, care and treatment in Ethiopia. Prevention, screening, and management of common co infections. Addis Ababa: FMOH FEBRUARY; 2018."},{"key":"1872_CR36","unstructured":"Le Thuy. World Health Organization Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2018."},{"issue":"4","key":"1872_CR37","doi-asserted-by":"publisher","first-page":"e06745","DOI":"10.1016\/j.heliyon.2021.e06745","volume":"7","author":"ES Chanie","year":"2021","unstructured":"Chanie ES, Bayih WA, Birhan BM, Belay DM, Asmare G, Tiruneh T, et al. Incidence of advanced opportunistic infection and its predictors among HIV infected children at Debre Tabor referral hospital and University of Gondar Compressive specialized hospitals, Northwest Ethiopia, 2020: a multicenter retrospective follow-up study. Heliyon. 2021;7(4):e06745.","journal-title":"Heliyon"},{"issue":"7","key":"1872_CR38","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/INF.0000000000000226","volume":"33","author":"W Prasitsuebsai","year":"2014","unstructured":"Prasitsuebsai W, Kariminia A, Puthanakit T, Lumbiganon P, Hansudewechakul R, Siew Moy F, et al. Impact of antiretroviral therapy on opportunistic infections of HIV-infected children in the therapeutic research, education and AIDS training asia pediatric HIV observational database. Pediatr Infect Dis J. 2014;33(7):747\u201352.","journal-title":"Pediatr Infect Dis J"},{"key":"1872_CR39","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s13312-018-1272-x","volume":"55","author":"UM Jha","year":"2018","unstructured":"Jha UM, Dhingra N, Raj Y, Rewari BB, Jeyaseelan L, Harvey P, et al. Survival of children living with human immunodeficiency virus on antiretroviral therapy in Andhra Pradesh, India. Indian Pediatr. 2018;55:301\u20135.","journal-title":"Indian Pediatr"},{"key":"1872_CR40","doi-asserted-by":"publisher","first-page":"1107321","DOI":"10.3389\/fped.2023.1107321","volume":"11","author":"GB Mekonnen","year":"2023","unstructured":"Mekonnen GB, Birhane BM, Engdaw MT, Kindie W, Ayele AD, Wondim A. Predictors of a high incidence of opportunistic infections among HIV-infected children receiving antiretroviral therapy at Amhara regional state comprehensive specialized hospitals, Ethiopia: a multicenter institution-based retrospective follow-up study. Front Pead. 2023;11:1107321.","journal-title":"Front Pead"},{"key":"1872_CR41","doi-asserted-by":"crossref","unstructured":"Ebonyi AO, Oguche S, Meloni ST, Sagay SA, Kyriacou DN, Achenbach CJ et al. Predictors of mortality in a clinic cohort of HIV-1 infected children initiated on antiretroviral therapy in Jos. Nigeria J AIDS Clin Res. 2014;5(12).","DOI":"10.4172\/2155-6113.1000403"},{"issue":"9448","key":"1872_CR42","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","volume":"364","author":"C Chintu","year":"2004","unstructured":"Chintu C, Bhat G, Walker A, Mulenga V, Sinyinza F, Lishimpi K, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865\u201371.","journal-title":"Lancet"},{"issue":"4","key":"1872_CR43","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0b013e318207a55b","volume":"56","author":"P Lumbiganon","year":"2011","unstructured":"Lumbiganon P, Kariminia A, Aurpibul L, Hansudewechakul R, Puthanakit T, Kurniati N, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011;56(4):365.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"1872_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-13-181","volume":"13","author":"SB Asafo-Agyei","year":"2013","unstructured":"Asafo-Agyei SB, Antwi S, Nguah SB. HIV infection in severely malnourished children in Kumasi, Ghana: a cross-sectional prospective study. BMC Pediatr. 2013;13(1):1\u20137.","journal-title":"BMC Pediatr"},{"issue":"4suppl4","key":"1872_CR45","first-page":"S313","volume":"31","author":"S De Pee","year":"2010","unstructured":"De Pee S, Semba RD. Role of nutrition in HIV infection: review of evidence for more effective programming in resource-limited settings. FoodNutr Bull. 2010;31(4suppl4):S313\u201344.","journal-title":"FoodNutr Bull"},{"issue":"6","key":"1872_CR46","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1086\/500398","volume":"42","author":"A Mangili","year":"2006","unstructured":"Mangili A, Murman DH, Zampini AM, Wanke CA, Mayer KH, Nutrition, Infection HIV. Review of weight loss and wasting in the era of highly active antiretroviral therapy from the Nutrition for Healthy Living Cohort. Clin Infect Dis. 2006;42(6):836\u201342.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1872_CR47","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1111\/j.1572-0241.2000.03365.x","volume":"95","author":"TA Knox","year":"2000","unstructured":"Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1872_CR48","doi-asserted-by":"publisher","first-page":"e0238403","DOI":"10.1371\/journal.pone.0238403","volume":"15","author":"BB Abate","year":"2020","unstructured":"Abate BB, Aragie TG, Tesfaw G. Magnitude of underweight, wasting and stunting among HIV positive children in East Africa: a systematic review and meta-analysis. PLoS ONE. 2020;15(9):e0238403.","journal-title":"PLoS ONE"},{"key":"1872_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-11-869","volume":"11","author":"BF Sunguya","year":"2011","unstructured":"Sunguya BF, Poudel KC, Otsuka K, Yasuoka J, Mlunde LB, Urassa DP, et al. Undernutrition among HIV-positive children in Dar Es Salaam, Tanzania: antiretroviral therapy alone is not enough. BMC Public Health. 2011;11:1\u201311.","journal-title":"BMC Public Health"},{"issue":"1","key":"1872_CR50","first-page":"1","volume":"48","author":"B Taye","year":"2010","unstructured":"Taye B, Shiferaw S, Enquselassie F. The impact of malnutrition in survival of HIV infected children after initiation of antiretroviral treatment (ART). Ethiop Med J. 2010;48(1):1\u201310.","journal-title":"Ethiop Med J"},{"key":"1872_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-10-33","volume":"10","author":"DC Wamalwa","year":"2010","unstructured":"Wamalwa DC, Obimbo EM, Farquhar C, Richardson BA, Mbori-Ngacha DA, Inwani I, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:1\u20138.","journal-title":"BMC Pediatr"},{"issue":"11","key":"1872_CR52","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.5588\/ijtld.13.0030","volume":"17","author":"W Buck","year":"2013","unstructured":"Buck W, Olson D, Kabue M, Ahmed S, Nchama L, Munthali A, et al. Risk factors for mortality in Malawian children with human immunodeficiency virus and tuberculosis co-infection. Int J Tuberc Lung Dis. 2013;17(11):1389\u201395.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"1872_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.medmal.2016.07.003","volume":"47","author":"AN Nlend","year":"2017","unstructured":"Nlend AN, Loussikila A. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy. Med et maladies Infectieuses. 2017;47(1):32\u20137.","journal-title":"Med et maladies Infectieuses"},{"issue":"7","key":"1872_CR54","doi-asserted-by":"publisher","first-page":"e22706","DOI":"10.1371\/journal.pone.0022706","volume":"6","author":"BC Zanoni","year":"2011","unstructured":"Zanoni BC, Phungula T, Zanoni HM, France H, Feeney ME. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS ONE. 2011;6(7):e22706.","journal-title":"PLoS ONE"},{"key":"1872_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-8-52","volume":"8","author":"A Johannessen","year":"2008","unstructured":"Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008;8:1\u201310.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"1872_CR56","first-page":"1462","volume":"3","author":"T Moshago","year":"2014","unstructured":"Moshago T, Haile DB, Enqusilasie F. Survival analysis of HIV infected people on antiretroviral therapy at Mizan-Aman General Hospital, Southwest Ethiopia. Int J Sci Res. 2014;3(5):1462\u20138.","journal-title":"Int J Sci Res"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01872-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01872-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01872-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:28:36Z","timestamp":1741350516000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01872-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1872"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01872-5","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Since, this study used secondary data or children medical records, the need for informed consent and ethical approval was waived by Institutional Review Board of the University of Gondar, College of Medicine and Health Sciences on behalf of the Ethical Review Committee of the School of Nursing (Ref.no SN\/228\/2014). A written permission letter was obtained from Amhara Public Health Institute for each Hospital (Ref.no APHI\/03\/1438). Finally, before collecting the data, a letter of permission to collect the data was obtained from the respective Comprehensive Specialized Hospital administrators to collect the data from each ART clinic. At the time of abstraction, personal identifiers (name and contact numbers) were excluded. The data were kept strictly confidential and used only for study purposes. All of the procedures were carried out by considering the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}